On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
On Oct. 14, 2025, researchers at Cincinnati Children’s in collaboration with Roche, have developed a next-generation human liver…
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…
On Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
On Sept. 3, 2025, C2N Diagnostics (C2N), a specialty diagnostics company announce that its early achievements while based…
On Aug. 29, 2025, the National Institutes of Health (NIH) announced it had awarded Duke University $69 million…
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
On Aug. 6, 2025, CareDx announced the publication of the Kidney Allograft Outcomes AlloSure Registry (KOAR) study in…
On Jul. 15, 2025, C2N Diagnostics (C2N), announces the launch of two new highly anticipated plasma assays for…
On Jun. 25, 2025, the National Institutes of Health (NIH) moved to reinstate about 900 grants that a…
On Jun. 11, 2025, a study led by by University of Barcelona experts Carles J. Ciudad and Verònica…
On Jul. 30, 2024, a head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by…
On Jun. 27, 2024, C2N Diagnostics (C2N), has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for…
On Feb. 24, 2024, C2N Diagnostics (C2N) announced the medical device registration from the United Kingdom’s Medicines and…
On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance COVID-19: Developing Drugs…
On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
On Aug. 29, 2016, Scripps Health and MD Anderson Cancer Center announced a partnership agreement to create Scripps…
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
On Jul. 22, 1993, revising a policy from 1977 that excluded women of childbearing potential from early drug…
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched. The trial was designed to determine whether…
In 1992, the National Cancer Institute (NCI) awarded the Pacific Health Research Institute its largest and most enduring…
In 1991, the American Association of Clinical Endocrinologists (AACE) was founded by a visionary group of leaders to…
On Jun. 25, 1988, the U.S. Postal Service (USPS) proposed to ban mailings of microbe samples capable of…
In 1988, the U.S. Food and Drug Administration (FDA) published a final rule, Annual Summary Reporting Requirements Under the…